Top mergers and acquisitions in China in July 2026
Every verified merger and acquisition involving China in this period, ranked by disclosed value. Updated every morning.
We tracked 2 deals involving China in July 2026, 2 of them with a disclosed value, worth $1.3bn in total. The largest was China Resources Double-Crane Pharmaceutical Co., Ltd.'s $840m deal for Lier Chemical Co., Ltd. (23.5% controlling stake), ahead of Guohai Securities Co., Ltd. and Datong Securities Co., Ltd. (51.59%) at $470m.
Top mergers and acquisitions in China in July 2026
- 129 JulChina Resources Double-Crane Pharmaceutical Co., Ltd. → Lier Chemical Co., Ltd. (23.5% controlling stake)China Resources Double-Crane agrees CNY5.66bn deal for control of Lier ChemicalChemicals / AgrochemicalsAgreed$840m
- 217 JulGuohai Securities Co., Ltd. → Datong Securities Co., Ltd. (51.59%)Guohai Securities wins CNY3.2bn auction for control of Datong SecuritiesFinancials / BrokerageIn review$470m